These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24789344)

  • 1. Breast-feeding and maternal risk of type 2 diabetes: a prospective study and meta-analysis.
    Jäger S; Jacobs S; Kröger J; Fritsche A; Schienkiewitz A; Rubin D; Boeing H; Schulze MB
    Diabetologia; 2014 Jul; 57(7):1355-65. PubMed ID: 24789344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of various biomarkers as potential mediators of the association between Δ5 desaturase, Δ6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.
    Jacobs S; Schiller K; Jansen EH; Boeing H; Schulze MB; Kröger J
    Am J Clin Nutr; 2015 Jul; 102(1):155-64. PubMed ID: 25971719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study.
    Jacobs S; Kröger J; Floegel A; Boeing H; Drogan D; Pischon T; Fritsche A; Prehn C; Adamski J; Isermann B; Weikert C; Schulze MB
    Am J Clin Nutr; 2014 Sep; 100(3):891-900. PubMed ID: 25057154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes.
    Montonen J; Drogan D; Joost HG; Boeing H; Fritsche A; Schleicher E; Schulze MB; Pischon T
    Eur J Epidemiol; 2011 Jan; 26(1):29-38. PubMed ID: 21188480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study.
    Jäger S; Jacobs S; Kröger J; Stefan N; Fritsche A; Weikert C; Boeing H; Schulze MB
    PLoS One; 2015; 10(4):e0124749. PubMed ID: 25902304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study.
    Montonen J; Boeing H; Steffen A; Lehmann R; Fritsche A; Joost HG; Schulze MB; Pischon T
    Diabetologia; 2012 Oct; 55(10):2613-2621. PubMed ID: 22752055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the German Diabetes Risk Score with metabolic risk factors for type 2 diabetes].
    Schulze MB; Boeing H; Häring HU; Fritsche A; Joost HG
    Dtsch Med Wochenschr; 2008 Apr; 133(17):878-83. PubMed ID: 18415912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors.
    Wittenbecher C; Kuxhaus O; Boeing H; Stefan N; Schulze MB
    Diabetologia; 2019 Dec; 62(12):2211-2221. PubMed ID: 31501920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohort.
    Heidemann C; Hoffmann K; Spranger J; Klipstein-Grobusch K; Möhlig M; Pfeiffer AF; Boeing H;
    Diabetologia; 2005 Jun; 48(6):1126-34. PubMed ID: 15889235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trajectories of metabolic risk factors and biochemical markers prior to the onset of type 2 diabetes: the population-based longitudinal Doetinchem study.
    Hulsegge G; Spijkerman AMW; van der Schouw YT; Bakker SJL; Gansevoort RT; Smit HA; Verschuren WMM
    Nutr Diabetes; 2017 May; 7(5):e270. PubMed ID: 28481339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fetuin-A levels and the risk of type 2 diabetes.
    Stefan N; Fritsche A; Weikert C; Boeing H; Joost HG; Häring HU; Schulze MB
    Diabetes; 2008 Oct; 57(10):2762-7. PubMed ID: 18633113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies.
    Stefan N; Sun Q; Fritsche A; Machann J; Schick F; Gerst F; Jeppesen C; Joost HG; Hu FB; Boeing H; Ullrich S; Häring HU; Schulze MB
    PLoS One; 2014; 9(3):e92238. PubMed ID: 24643166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response association between the triglycerides: High-density lipoprotein cholesterol ratio and type 2 diabetes mellitus risk: The rural Chinese cohort study and meta-analysis.
    Cheng C; Liu Y; Sun X; Yin Z; Li H; Zhang M; Zhang D; Wang B; Ren Y; Zhao Y; Liu D; Zhou J; Liu X; Liu L; Chen X; Liu F; Zhou Q; Hu D
    J Diabetes; 2019 Mar; 11(3):183-192. PubMed ID: 30091266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis.
    Lee CC; Adler AI; Sandhu MS; Sharp SJ; Forouhi NG; Erqou S; Luben R; Bingham S; Khaw KT; Wareham NJ
    Diabetologia; 2009 Jun; 52(6):1040-7. PubMed ID: 19326095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetuin-A and risk of diabetes-related vascular complications: a prospective study.
    Birukov A; Polemiti E; Jäger S; Stefan N; Schulze MB
    Cardiovasc Diabetol; 2022 Jan; 21(1):6. PubMed ID: 34998417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study.
    ; Scott RA; Langenberg C; Sharp SJ; Franks PW; Rolandsson O; Drogan D; van der Schouw YT; Ekelund U; Kerrison ND; Ardanaz E; Arriola L; Balkau B; Barricarte A; Barroso I; Bendinelli B; Beulens JW; Boeing H; de Lauzon-Guillain B; Deloukas P; Fagherazzi G; Gonzalez C; Griffin SJ; Groop LC; Halkjaer J; Huerta JM; Kaaks R; Khaw KT; Krogh V; Nilsson PM; Norat T; Overvad K; Panico S; Rodriguez-Suarez L; Romaguera D; Romieu I; Sacerdote C; Sánchez MJ; Spijkerman AM; Teucher B; Tjonneland A; Tumino R; van der A DL; Wark PA; McCarthy MI; Riboli E; Wareham NJ
    Diabetologia; 2013 Jan; 56(1):60-9. PubMed ID: 23052052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma
    Wittenbecher C; Štambuk T; Kuxhaus O; Rudman N; Vučković F; Štambuk J; Schiborn C; Rahelić D; Dietrich S; Gornik O; Perola M; Boeing H; Schulze MB; Lauc G
    Diabetes Care; 2020 Mar; 43(3):661-668. PubMed ID: 31915204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study.
    Mozaffarian D; Cao H; King IB; Lemaitre RN; Song X; Siscovick DS; Hotamisligil GS
    Ann Intern Med; 2010 Dec; 153(12):790-9. PubMed ID: 21173413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study.
    Stringhini S; Tabak AG; Akbaraly TN; Sabia S; Shipley MJ; Marmot MG; Brunner EJ; Batty GD; Bovet P; Kivimäki M
    BMJ; 2012 Aug; 345():e5452. PubMed ID: 22915665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of breast-feeding and the incidence of type 2 diabetes mellitus in the Shanghai Women's Health Study.
    Villegas R; Gao YT; Yang G; Li HL; Elasy T; Zheng W; Shu XO
    Diabetologia; 2008 Feb; 51(2):258-66. PubMed ID: 18040660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.